Skip to main content
TipRanks
Go Ultimate75% OFF

Infinity Pharmaceuticals (INFIQ) Stock Price & Analysis

912 Followers

INFIQ Stock Chart & Stats

$0.00$0.00(0.00%)
At close: 11:54 AM EDT
$0$0.1$0.2Jul 3Jul 17Jul 31Aug 14Aug 28Sep 11Sep 25
Day’s Range
$0.01 - $0.02
52-Week Range
N/A
Previous Close
$0.02
Volume
N/A
Average Volume (3M)
2.27M
Market Cap
$91
Enterprise Value
$49.63M
Total Cash (Recent Filing)
$17.75M
Total Debt (Recent Filing)
$633.00K
Price to Earnings (P/E)
0.0
Beta
-110.71
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

INFIQ FAQ

What is Infinity Pharmaceuticals’s market cap?
Infinity Pharmaceuticals’s market cap is $91.
When is Infinity Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Infinity Pharmaceuticals’s earnings last quarter?
Infinity Pharmaceuticals released its earnings results on Aug 08, 2023. The company reported -$0.111 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.009.
Is Infinity Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Infinity Pharmaceuticals pay dividends?
Infinity Pharmaceuticals does not currently pay dividends.
What is Infinity Pharmaceuticals’s EPS estimate?
Infinity Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Infinity Pharmaceuticals have?
Infinity Pharmaceuticals has 90,761,080 shares outstanding.
What happened to Infinity Pharmaceuticals’s price movement after its last earnings report?
Infinity Pharmaceuticals reported an EPS of -$0.111 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went up 44.444%.
Which hedge fund is a major shareholder of Infinity Pharmaceuticals?
Currently, no hedge funds are holding shares in INFIQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology